new_0222_0420|AVTE|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0420|AVTE|1|Aerovate Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aerovate Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aerovate Therapeutics Inc Inventories (Quarterly) (USD)|Aerovate Therapeutics Inc Net PP&E (Quarterly) (USD)|Aerovate Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aerovate Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aerovate Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aerovate Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aerovate Therapeutics Inc Total Deposits (Quarterly) (USD)|Aerovate Therapeutics Inc Book Value (Quarterly) (USD)|Aerovate Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aerovate Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aerovate Therapeutics Inc EV to Revenues|Aerovate Therapeutics Inc EV to Earnings|Aerovate Therapeutics Inc EV to Free Cash Flow|Aerovate Therapeutics Inc EV to Assets (Quarterly)|Aerovate Therapeutics Inc PS Ratio|Aerovate Therapeutics Inc PE Ratio|Aerovate Therapeutics Inc Price to Book Value|Aerovate Therapeutics Inc PEG Ratio|Aerovate Therapeutics Inc Debt to Equity Ratio|Aerovate Therapeutics Inc Dividend Yield|Aerovate Therapeutics Inc Shareholder Yield (TTM)|Aerovate Therapeutics Inc Percent of Shares Outstanding Short|Aerovate Therapeutics Inc Total Receivables (Quarterly) (USD)|Aerovate Therapeutics Inc Total Payables (Quarterly) (USD)|Aerovate Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aerovate Therapeutics Inc Return on Invested Capital|Aerovate Therapeutics Inc Quality Ratio Score|Aerovate Therapeutics Inc Momentum Score|Aerovate Therapeutics Inc Beta (1Y)|Aerovate Therapeutics Inc Sustainable Growth Rate (TTM)|Aerovate Therapeutics Inc Institutional Investor Ownership Percentage|Aerovate Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aerovate Therapeutics Inc Total Employees (Annual)|Aerovate Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aerovate Therapeutics Inc Shares Outstanding|Aerovate Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aerovate Therapeutics Inc Ordinary Shares Number (Quarterly)|Aerovate Therapeutics Inc Payout Ratio|Aerovate Therapeutics Inc Quick Ratio (Quarterly)|Aerovate Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aerovate Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aerovate Therapeutics Inc Effective Tax Rate (TTM)|Aerovate Therapeutics Inc Return on Equity|Aerovate Therapeutics Inc Net Income (TTM) (USD)|Aerovate Therapeutics Inc Revenue (TTM) (USD)|Aerovate Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aerovate Therapeutics Inc Revenue (Quarterly) (USD)|Aerovate Therapeutics Inc Gross Profit (Quarterly) (USD)|Aerovate Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aerovate Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aerovate Therapeutics Inc Net Income (Quarterly) (USD)|Aerovate Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aerovate Therapeutics Inc Price (USD)|Aerovate Therapeutics Inc Total Return Price (USD)|Aerovate Therapeutics Inc Enterprise Value (USD)|Aerovate Therapeutics Inc 30-Day Average Daily Volume|Aerovate Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0420|AVTE|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0420|AVTE|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_0222_0420|AVTE|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.44099378882|0|0|0|1.4387755102|0|0|1.44099378882|0|15.3571428571|0|91|91|0|0|0|0|0|0|91.3333333333|50|91.3333333333|28.2|0|91|0|0|91.3333333333|91.25|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43827160494|1.43827160494|1.44099378882|1.43939393939|0||
new_0222_0420|AVTE|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|161|0|0|0|98|0|0|161|0|14|0|3|3|0|0|0|0|0|0|6|2|6|5|0|3|0|0|6|4|0|0|3|0|0|0|0|6|6|6|6|162|162|161|132|0||
new_0222_0420|AVTE|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0420|AVTE|202003||||||||||||||||||||||||||||||||||4.4967||-0.3193||||||-0.3193|||||||||0.152|-1.436|-1.436|-0.038|||||||
new_0222_0420|AVTE|202006||||||||||||||||||||||||||||||||||4.4967||-0.4897||||||-0.4897|||||||||0.154|-2.202|-2.202|-0.037|||||||
new_0222_0420|AVTE|202009||||||||||||||||||||||||||||||||||4.4967||-0.5471||||||-0.513|0||||||||0.277|-2.307|-2.307|0|||||||
new_0222_0420|AVTE|202012|4.676|4.573||0.039||18.059|1.774|16.285||-13.344|-13.407|||||||||||||||0.618|0|||||||4.4967||-0.8153|||23.1081|||-0.8153||||-9.611|||||0.366|-3.666|-3.666|0|||||||
new_0222_0420|AVTE|202103|9.604|8.641||0.037||26.063|1.782|24.281||-16.115|-16.201|||||||||||||||1.55|0|||||||4.4967||-0.62|||23.1081|||-0.62||||-10.956|||||0.584|-2.781|-2.781|0|||||||
new_0222_0420|AVTE|202106|59.309|59.15||0.035||84.012|4.193|79.819||-21.578|-21.985||||-35.7645|||||||0||0||3.042|0||||||86.4977|23.1081|8|-0.2503|23.1081||23.1081|||-0.2503||||-14.529|||||1.447|-5.775|-5.775|0.002|22.83|22.83|468.4079|73561.3667||12.85|17.09
new_0222_0420|AVTE|202109|183.102|180.878||0.745||4.277|3.825|0.452||179.848|-28.169||||-19.2701||||2.8476|||0||4.5614||2.555|0.002|||||||23.885|8|-0.26|24.4104||24.4104|||-0.26|-127.195|||-18.406|||||2.782|-6.184|-6.184|0.016|20.98|20.98|331.2522|181950.6||15.93|13.71
new_0222_0420|AVTE|202112|||||||||||||||-6.2199||||1.6002|||0||1.8277|||||||||||||||||||||||||||||||11.79|11.79|106.9206|88040.9333||11.82|8.55